Clinical Trials Sponsored by Prodeco Pharma

Total 8617 results

Franklin Health Research
Prodeco Pharma

Completed

Aromatherapy for Upper Respiratory Health

Immune System

United States
Proveca Pharma Limited

Recruiting

Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties, (SALIVA)

Neurodevelopmental Disorders | Sialorrhea

France
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Valhalla Project Niagara

Recruiting

Residential Retreat for Veterans and First-responders

PTSD

Canada
Pachyonychia Congenita Project

Recruiting

International Pachyonychia Congenita Research Registry (IPCRR)

Pachyonychia Congenita

United States
Bandim Health Project

Completed

A Second Dose of Measles Vaccine (MV) in the Second Year of Life

Child Mortality | Child Morbidity

Guinea-Bissau
Bandim Health Project

Enrolling by invitation

Measles Vaccination at Health System Contacts

Mortality | Measles Vaccine | Hospital Admission | Non-specific (Heterologous) Effects of Vaccines

Guinea-Bissau
Bandim Health Project

Unknown

Additional Measles Vaccine at 4 Months of Age

Measles Infection

Guinea-Bissau
Bandim Health Project

Unknown

Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity

Mortality | Morbidity

Guinea-Bissau
Bandim Health Project

Completed

Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality

Mortality | Morbidity

Guinea-Bissau
Bandim Health Project

Unknown

The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau

Malaria | Falciparum

Guinea-Bissau
Bandim Health Project

Completed

Impact of Exclusive Breast-Feeding in Guinea Bissau

Nutritional Status

Guinea-Bissau
Prodeon Medical, Inc

Recruiting

The Expander-2 Trial: A Randomized Study to Evaluate the Safety and Efficacy of the Urocross(TM) Expander System and Retrieval Sheath

Benign Prostatic Hyperplasia

United States
Bandim Health Project

Completed

Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria

Malaria | Effectiveness

Guinea-Bissau
Bandim Health Project

Active, not recruiting

OPV as Potential Protection Against COVID-19

Mortality | COVID | Morbidity | Poliovirus Vaccine, Oral | Non-Specific Effects of Vaccines

Guinea-Bissau
Bandim Health Project

Completed

Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2

Malaria

Guinea-Bissau
Bandim Health Project

Completed

Low Birth Weight Follow-up

Low Birth Weight | Non Specific Effects of Vaccine | Bacillus-Calmette-Guerin | Maternal Immunisation

Guinea-Bissau
Bandim Health Project

Terminated

A Randomized Trial of Providing BCG Vaccination Immediately

Early Neonatal Mortality

Guinea-Bissau
Bandim Health Project

Unknown

Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth

Healthy | Infant, Newborn

Guinea-Bissau
Bandim Health Project

Completed

Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau

Malaria, Falciparum

Guinea-Bissau
Pachyonychia Congenita Project

Completed

Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita

Pachyonychia Congenita

United States
Bandim Health Project

Completed

Different Doses of Vitamin A and Childhood Morbidity and Mortality

Mortality | Morbidity

Guinea-Bissau
Documenting Hope Project

Recruiting

FLIGHT Study for Childhood Chronic Illness

Chronic Illnesses, Multiple

United States
Bandim Health Project

Completed

Artemether-Lumefantrine Effectiveness in Guinea-Bissau

Malaria

Guinea-Bissau
Parent Project, Italy

Completed

To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20 (ISOFEN1)

Duchenne Muscular Dystrophy (DMD)

Italy
Bandim Health Project

Unknown

mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau (mimi)

Measles

Guinea-Bissau
Bandim Health Project

Completed

Pharmacokinetic Study of Multi-dose Chloroquine

Malaria

Guinea-Bissau
Bandim Health Project

Unknown

Vitamin A Supplementation at Birth and Atopy in Childhood

Asthma | Eczema | Food Allergy | Atopy

Guinea-Bissau
Bandim Health Project

Completed

The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children

Malaria, Falciparum

Guinea-Bissau
Bandim Health Project

Completed

Chloroquine and Amodiaquine for Treatment of Malaria in Children

Malaria, Falciparum

Guinea-Bissau
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy
UCB Pharma SA

Completed

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Dermatitis, Atopic
UCB Pharma SA

Completed

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] (PRECiSE 3)

Crohn's Disease

United States, Australia, Austria, Belarus, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, Canada and more
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
UCB Pharma SA

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Unverricht-Lundborg Disease

France, Italy, Sweden, Finland, Netherlands, Tunisia, Réunion
UCB Pharma SA

Completed

Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects

Healthy Volunteers

United Kingdom
UCB Pharma SA

Terminated

Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease (REFRESH-PD)

Advanced Idiopathic Parkinson's Disease

United Kingdom
Astellas Pharma Inc
Advanz Pharma

Completed

Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

Atrial Fibrillation | Atrial Flutter

United States, Argentina, Canada, Chile, Denmark, Mexico, Sweden

Clinical Trials Sponsored by Prodeco Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations